Cyclic peptide inhibitors of phosphatidylinositol 3-kinase p85 SH2 domain binding

19Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Cyclic hexameric peptides based on the amino acid sequence “Gly-Xxx-Val- Pro-Met-Leu”, where Xxx is either phosphotyrosyl (pTyr) residue or a hydrolytically stable pTyr mimetic, were examined for their ability to bind to the C-terminal SH2 domain of the p85 phosphoinositol 3-kinase (PI 3- kinase). The cyclic peptides retained significant binding affinity relative to their linear counterparts. Potency varied depending on Xxx in the order: phosphonomethyl phenylalanine (Pmp, ID50 = 5.2 μM) < phosphonodifluoromethyl phenylalanine (F2Pmp, ID50 = 2.2 μM) 500 M). Greatly reduced potency was observed when Xxx was of the unnatural D-configuration. The cyclic peptides represent conformationally constrained ligands which should be useful in the development of p85 SH2 domain-directed inhibitors. © Academic Press, Inc.

Cite

CITATION STYLE

APA

Burke, T. R., Nomizu, M., Otaka, A., Smyth, M. S., Roller, P. P., Case, R. D., … Shoelson, S. E. (1994). Cyclic peptide inhibitors of phosphatidylinositol 3-kinase p85 SH2 domain binding. Biochemical and Biophysical Research Communications, 201(3), 1148–1153. https://doi.org/10.1006/bbrc.1994.1825

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free